Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
The latest dividend from ORMP was $0.25 per share (ex-dividend 1/16/2026). The dividend yield over the last 12 months is 0%. Over the last 12 months there was 1 distribution, totalling $0.25 per share.